Product Information

Synonyms: piracetam

Keywords: noötropic, cognition, memory, dementia, epilepsy, stroke, aging, Raynaud’s, thrombosis


NoöRacetam is LifeLink’s brand of piracetam. Piracetam, a derivative of the neurotransmatter GABA, is a racetam — a category of cognitive enhancers that includes aniracetam, pramiracetam, oxiracetam, and others. Cognitive enhancers are also called “noötropics”.

Piracetam was first of the noötropics. Discovered in 1964, it has been in clinical and popular use in Europe and elsewhere since the early 1970s. In the U.S., however, government bureaucrats have waged a campaign against piracetam and other noötropics, using scare tactics1 and gestapo-type actions2,3 to prevent U.S. citizens from having access to them. Despite the harrassment, many people have quietly imported small quantities from Europe for their own use.

In view of the fact that piracetam is a simple derivative of the neurotransmitter GABA and has a proven lack of toxicity, it was adopted in 2006 as a nutritional supplement by U.S. supplement companies.

What we can’t tell you

In the U.S. and some other industrialized countries, government agencies like the U.S. Food and Drug Administration have adopted censorship as a method for intensifying their control over the supplement industry and its customers. Thus, FDA regulations prohibit us from telling you that any of our products are effective as medical treatments, even if they are, in fact, effective.

Accordingly, we will limit our discussion of NoöRacetam to a brief summary of relevant research, and let you draw your own conclusions about what medical conditions it may be effective in treating.


During its more than 30 years of use in Europe, piracetam has been used to treat a variety of conditions, and benefits have been reported in the following areas:

  • cognitive enhancement for students4
  • dyslexia5
  • stroke6
  • epilepsy7
  • myoclonus8,7
  • dementia8
  • alcoholism9
  • lipofuscin build-up (symptom of aging)10
  • Raynaud’s syndrome11
  • deep vein thrombosis12
  • tardive dyskinesia13
Mechanism of action

Piracetam’s effects on both nerve cells and on blood may be explained by the fact that it alters the fluidity of membranes of cells.14 Such a change in fluidity would affect the function of various proteins that float in these membranes — proteins such as ion channels in nerve cell membranes, and metabolic enzymes in mitochondrial membranes. Cell membrane fluidity would also affect the ability of blood cells to pass through small veins and capillaries.


Among the many good reviews of this topic are the ones at UC Berkeley’s Sulcus website15, at Wikipedia16, and the one by Winnicka.8


Piracetam has an excellent reputation for being nontoxic.16,17 Many clinical studies have shown this supplement to be safe to use, even in very high doses.18,19,20,21 Human oral doses as high as 45 grams during 12 hours have been reported to be without ill effects.22


The recommended dosage of piracetam ranges from 1.6-9.6 grams per day, taken in divided doses. For blood disorders the usual dosage is 4.8 to 9.6 grams per day divided into three doses about 8 hours apart.

A question to ponder

Why has the U.S. government tried to prevent its citizens from having access to noötropics like piracetam? The official reason is “to keep the public safe” — this is the standard excuse given for police-state behavior. A more plausible explanation might be “to keep the public from becoming too smart”. A smarter public would be less tolerant of corrupt and incompetent government officials.


Piracetam should be avoided by people with severe impairment of liver or kidneys, or with cerebral hemorrhage. If piracetam is to be discontinued, the dosage should be reduced gradually over a period of several days.


Are NoöRacetam supplements useful for the conditions and purposes mentioned above? We aren’t allowed to tell you, so you should take a look at some of the references cited here, and then decide for yourself.

40320 800 mg 90 capsules 3 capsules $28.55
(12% off!)

Pronunciation: NoöRacetam nō′·ō·ras′·ǝ·tam, racetam ras′·ǝ·tam, piracetam pır·ras′·ǝ·tam

— RM

Last modified 2010.09.01